Entero Healthcare Solutions (NSE:ENTERO) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
68 GF Score
Price ₹1,416.60
GF Value ₹1,735.94
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Short-Term Debt?

Entero Healthcare Solutions NSE:ENTERO -2.17% 68 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 68/100 and a GF Value™ of ₹1,735.94 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Entero Healthcare Solutions's Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Entero Healthcare Solutions's quarterly Short-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹4,441 Mil) but then declined from Mar. 2026 (₹4,441 Mil) to Jun. 2026 (₹0 Mil).

Entero Healthcare Solutions's annual Short-Term Debt increased from Mar. 2024 (₹2,300 Mil) to Mar. 2025 (₹2,988 Mil) and increased from Mar. 2025 (₹2,988 Mil) to Mar. 2026 (₹4,441 Mil).

Entero Healthcare Solutions Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Entero Healthcare Solutions Short-Term Debt Related Terms

Entero Healthcare Solutions Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Short-Term Debt Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial 2,479.02 3,432.48 2,300.11 2,988.11 4,441.23

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3,257.22 0.00 4,441.23 0.00
NSE:ENTERO
68GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Entero Healthcare Solutions' Short-Term Debt too high?
Entero Healthcare Solutions' current Short-Term Debt is ₹0 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Short-Term Debt compare to MCK and COR?
Entero Healthcare Solutions' Short-Term Debt of ₹0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Entero Healthcare Solutions's current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,735.94, compared to a current price of ₹1,416.60 — trading 18.4% below its estimated fair value. The current Short-Term Debt is ₹0 Mil. Entero Healthcare Solutions' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?

Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be undervalued. The current stock price of ₹1,416.60 is trading 18.4% below its estimated GF Value™ of ₹1,735.94. GuruFocus considers Entero Healthcare Solutions to be Modestly Undervalued.

Key valuation signals for NSE:ENTERO:

  • Short-Term Debt: ₹0 Mil
  • GF Value™: ₹1,735.94 vs. price of ₹1,416.60 (18.4% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
68GF Score

Get the complete analysis for NSE:ENTERO

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,416.60
Price
₹1,735.94
GF Value